128 related articles for article (PubMed ID: 20406046)
1. Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.
Adamcová M; Potáčová A; Popelová O; Štěrba M; Mazurová Y; Aupperle H; Geršl V
Physiol Res; 2010; 59(5):831-836. PubMed ID: 20406046
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of matrix metalloproteinases on the model of daunorubicin-induced cardiomyopathy in rabbits.
Potácová A; Adamcová M; Sterba M; Popelová O; Simůnek T; Mazurová Y; Guncová I; Gersl V
Acta Medica (Hradec Kralove); 2007; 50(2):109-11. PubMed ID: 18035747
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterases in dexrazoxane-treated daunorubicin cardiomyopathy in rabbits.
Gersl V; Bajgar J; Hrdina R; Mazurová Y; Machácková J; Cerman J; Suba P
Gen Physiol Biophys; 1999 Dec; 18(4):335-46. PubMed ID: 10766032
[TBL] [Abstract][Full Text] [Related]
4. Protein profiling in daunorubicin-induced cardiomyopathy.
Adamcová M; Pelouch V; Gersl V; Kaplanová J; Mazurová Y; Simůnek T; Klimtová I; Hrdina R
Gen Physiol Biophys; 2003 Sep; 22(3):411-9. PubMed ID: 14986890
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium 2,3-dimercaptopropane-1-sulphonate (DMPS) on chronic daunorubicin toxicity in rabbits: comparison with dexrazoxane.
Hrdina R; Gersl V; Klimtová I; Simůnek T; Mazurová Y; Machácková J; Adamcová M
Acta Medica (Hradec Kralove); 2002; 45(3):99-105. PubMed ID: 12515046
[TBL] [Abstract][Full Text] [Related]
6. Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat.
Burke BE; Gambliel H; Olson RD; Bauer FK; Cusack BJ
Br J Pharmacol; 2000 Sep; 131(1):1-4. PubMed ID: 10960060
[TBL] [Abstract][Full Text] [Related]
7. Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
Kollárová-Brázdová P; Lenčová-Popelová O; Karabanovich G; Kocúrová-Lengvarská J; Kubeš J; Váňová N; Mazurová Y; Adamcová M; Jirkovská A; Holečková M; Šimůnek T; Štěrbová-Kovaříková P; Roh J; Štěrba M
Clin Sci (Lond); 2021 Aug; 135(15):1897-1914. PubMed ID: 34318878
[TBL] [Abstract][Full Text] [Related]
8. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M
Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762
[TBL] [Abstract][Full Text] [Related]
9. Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathy.
Simůnek T; Klimtová I; Adamcová M; Gersl V; Hrdina R; Sterba M; Kaplanová J; Mazurová Y
Cancer Chemother Pharmacol; 2003 Nov; 52(5):431-4. PubMed ID: 14618274
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbits.
Herman EH; Ferrans VJ
Cancer Chemother Pharmacol; 1986; 16(2):102-6. PubMed ID: 3081268
[TBL] [Abstract][Full Text] [Related]
11. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.
Cusack BJ; Gambliel H; Musser B; Hadjokas N; Shadle SE; Charlier H; Olson RD
Cancer Chemother Pharmacol; 2006 Oct; 58(4):517-26. PubMed ID: 16555089
[TBL] [Abstract][Full Text] [Related]
12. Troponins in experimental studies.
Adamcová M; Gersl V; Machácková J; Hrdina R; Klimtová I; Simůnek T; Vávrová J; Bukac J
Acta Medica (Hradec Kralove); 2002; 45(1):29-32. PubMed ID: 12143108
[TBL] [Abstract][Full Text] [Related]
13. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat.
Xu X; Ding F; Pang J; Gao X; Xu RK; Hao W; Cao JM; Chen C
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(6):H703-11. PubMed ID: 22842067
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting effect of dexrazoxane against anthracycline cardiotoxicity in rats.
Della Torre P; Podesta A; Pinciroli G; Iatropoulos MJ; Mazué G
Toxicol Pathol; 1996; 24(4):398-402. PubMed ID: 8864181
[TBL] [Abstract][Full Text] [Related]
15. Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits.
Simůnek T; Sterba M; Holecková M; Kaplanová J; Klimtová I; Adamcová M; Gersl V; Hrdina R
Biometals; 2005 Apr; 18(2):163-9. PubMed ID: 15954742
[TBL] [Abstract][Full Text] [Related]
16. [Myocardial matrix metalloproteinases activities in mice with viral myocarditis and their relationship with cardiac function and myocardial collagen amount].
Meng XH; Wang Y; Zhuang JX; Chen Y; Jin YP; Han XZ; Wang YL
Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):605-8. PubMed ID: 15347449
[TBL] [Abstract][Full Text] [Related]
17. Oligomeric proanthocyanidins protect myocardium by mitigating left ventricular remodeling in isoproterenol-induced postmyocardial infarction.
Rathinavel A; Sankar J; Mohammed Sadullah SS; Niranjali Devaraj S
Fundam Clin Pharmacol; 2018 Feb; 32(1):51-59. PubMed ID: 29059499
[TBL] [Abstract][Full Text] [Related]
18. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane.
Sawyer DB; Fukazawa R; Arstall MA; Kelly RA
Circ Res; 1999 Feb; 84(3):257-65. PubMed ID: 10024299
[TBL] [Abstract][Full Text] [Related]
19. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
Voloshenyuk TG; Gardner JD
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
[TBL] [Abstract][Full Text] [Related]
20. Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents.
Simůnek T; Klimtová I; Kaplanová J; Mazurová Y; Adamcová M; Sterba M; Hrdina R; Gersl V
Eur J Heart Fail; 2004 Jun; 6(4):377-87. PubMed ID: 15182761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
